SNMMI Leadership Update: SNMMI Mid-Winter and ACNM Annual Meeting in San Francisco

Virginia Pappas

Following SNMMI’s successful in-person 2022 Annual Meeting, the society is excited to bring the nuclear medicine and molecular imaging community together again at the 2023 SNMMI Mid-Winter and American College of Nuclear Medicine (ACNM) Annual Meeting. The meeting will be held January 26–28 in San Francisco, CA, for in-person attendees, and the full event will also be available online.

The SNMMI Mid-Winter and ACNM Annual Meeting is attended by leading molecular imaging and nuclear medicine physicians, radiologists, cardiologists, physicists, pharmacists, scientists, lab professionals, and technologists, representing the world’s top medical and academic institutions and centers. This year’s meeting will feature 3 educational tracks highlighting the latest innovations and techniques in the field, including a dedicated track on neuroimaging. All 3 tracks will be live-streamed, and content will be captured for on-demand viewing.

The ACNM Annual Meeting Track will include a robust program of cutting-edge educational content and oral presentations. Radionuclide therapy will be a main topic, with sessions on thyroid, neuroendocrine tumor, prostate-specific membrane antigen (PSMA), and pediatric imaging. A Read with the Experts session will feature new radiopharmaceuticals (FES, DOTATATE, and PyL), and a session on implementing new programs for infection and theranostics will also be presented.

Neuroimaging is always a hot topic, as evidenced in the recent Journal of Nuclear Medicine supplement “Molecular Imaging of Neurodegeneration: The Way to New Horizons” (https://jnm.snmjournals.org/content/63/Supplement_1). The Brain Imaging Track will feature sessions to improve attendees’ knowledge about neuroimaging, from basic concepts to more advanced applications. The track will address several important subjects, including acute rapid-onset dementing disorders, imaging of immune function in psychiatric conditions, imaging of epilepsy, and more.

The General Nuclear Medicine Track will include a wide-ranging scope of sessions developed and led by experts from SNMMI’s specialty councils and centers of excellence. These sessions are designed to expand attendees’ knowledge of the latest clinical applications and best practices in the field to advance precision medicine. Topics will cover artificial intelligence in nuclear cardiology, PSMA radiopharmaceutical therapy, clinical PET/MRI of the abdomen and pelvis, and hybrid PET/CT cardiac imaging.

In addition to the 3 tracks, the ACNM Annual Meeting track will feature a moderated poster session on Friday, January 27, where attendees can meet abstract authors, ask questions, and have discussions. Clinical and scientific abstracts presented at the meeting will cover aspects of clinical and basic science in nuclear medicine, correlative imaging in nuclear medicine and radiology, methodology (including computer programming or physics), nuclear pharmacy and physics, nuclear cardiology, theranostics, and quality and safety in nuclear medicine.

The meeting’s exhibit hall will offer attendees opportunities to connect with top nuclear medicine and molecular imaging companies to explore the latest technologies and products. The exhibit hall will be open on Friday, January 27, from 12:00 pm until 7:00 pm PST and on Saturday, January 28, from 9:30 am to 4:00 pm PST. Several breaks will be held throughout the meeting during which attendees can visit the exhibit hall. In addition, an exhibit hall reception will be held on Friday, January 27, from 5:45 to 7:00 pm PST; all attendees are welcome to join in this fun and informational event.

The ACNM Awards Ceremony and Banquet will be held immediately following the exhibit hall reception. During this event the ACNM will honor its 2023 Lifetime Achievement Award and 2023 Gold Medal Award winners, present the ACNM Abstract Awards, and induct its 2023 Class of Fellows.

The 2023 meeting title sponsor is Advanced Accelerator Applications, and the Brain Imaging Track sponsors are Eisai and Lilly. SNMMI thanks these and the meeting’s other sponsors for their support of the nuclear medicine and molecular imaging field.

The SNMMI Mid-Winter and ACNM Annual Meeting will be held at the Hyatt Regency San Francisco. This waterfront hotel is located steps from the Embarcadero, Union Square, and dozens of other destinations, allowing attendees easy access to Oracle Park, Alcatraz Island, the Exploratorium, and much more.

We have a wonderful program planned. You won’t want to miss it!

To register for the 2023 SNMMI Mid-Winter and ACNM Annual Meeting, visit www.snmmi.org/mwm. Early-bird registration ends December 15, 2022. We look forward to seeing you in San Francisco!